NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

PROF

Profound Medical Corp

Jun 30 • 04:00PM ET

5.90

Dollar change -0.10
Percentage change -1.67	%

Healthcare • Medical Devices • Canada • NASD

Peers: ISRG BSX INMD BDX HOLX CLPT EDAP ATEC CUTR NUWE

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.21	Insider Own	11.55%	Shs Outstand	30.05M	Perf Week	-1.83%
Market Cap	177.30M	Forward P/E	-	EPS next Y	-1.19	Insider Trans	0.64%	Shs Float	26.58M	Perf Month	10.69%
Enterprise Value	135.75M	PEG	-	EPS next Q	-0.37	Inst Own	43.30%	Short Float	2.23%	Perf Quarter	-2.48%
Income	-31.95M	P/S	14.95	EPS this Y	-20.98%	Inst Trans	-4.62%	Short Ratio	8.29	Perf Half Y	-15.47%
Sales	11.86M	P/B	3.49	EPS next Y	12.18%	ROA	-54.20%	Short Interest	0.59M	Perf YTD	-21.44%
Book/sh	1.69	P/C	3.82	EPS next 5Y	-10.35%	ROE	-66.36%	52W High	11.42 -48.34%	Perf Year	-33.44%
Cash/sh	1.55	P/FCF	-	EPS past 3/5Y	9.19% 3.91%	ROIC	-57.67%	52W Low	3.89 51.48%	Perf 3Y	-24.26%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	15.83% 20.72%	Gross Margin	72.80%	Volatility	5.64% 6.72%	Perf 5Y	-61.00%
Dividend TTM	-	EV/Sales	11.45	EPS Y/Y TTM	6.42%	Oper. Margin	-306.41%	ATR (14)	0.38	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	10.03	Sales Y/Y TTM	75.02%	Profit Margin	-269.36%	RSI (14)	49.59	Recom	1.25
Dividend Gr. 3/5Y	- -	Current Ratio	11.31	EPS Q/Q	-31.73%	SMA20	-3.91%	Beta	0.49	Target Price	11.31
Payout	-	Debt/Eq	0.10	Sales Q/Q	82.14%	SMA50	9.73%	Rel Volume	0.40	Prev Close	6.00
Employees	142	LT Debt/Eq	0.09	Earnings	May 08 AMC	SMA200	-12.06%	Avg Volume	71.41K	Price	5.90
IPO	Jun 09, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-27.43% -21.17%	Trades		Volume	30,706	Change	-1.67%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-23-24	Initiated	Lake Street	Buy	$16.50
Jul-16-24	Upgrade	Stifel	Hold → Buy	$9 → $12
Nov-28-23	Initiated	Stifel	Hold	$11
Aug-04-23	Downgrade	Raymond James	Strong Buy → Outperform	$20 → $200
Mar-21-23	Downgrade	Jefferies	Buy → Hold	$5.50 → $10
Sep-15-20	Initiated	Jefferies	Buy

Jun-25-25 04:09AM	Profound Medical Completes First Commercial BPH Treatment With New TULSA-AI Volume Reduction Module (Insider Monkey)
Jun-10-25 08:00AM	Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO with TULSA-AI Volume Reduction (GlobeNewswire) +17.39%
Jun-04-25 07:45AM	Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO (GlobeNewswire)
May-14-25 04:45PM	Profound Medical Annual General and Special Meeting of Shareholders Voting Results (GlobeNewswire) -5.39% +12.13%
May-09-25 03:40AM	Profound Medical Corp (PROF) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ... (GuruFocus.com) -7.03%
06:20PM	Loading…
May-08-25 06:20PM	Profound Medical (PROF) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Profound Medical Announces First Quarter 2025 Financial Results (GlobeNewswire)
May-07-25 11:16AM	Profound Medical Corp (TSX:PRN) Q1 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
May-05-25 09:57AM	Strength Seen in Profound Medical (PROF): Can Its 8.3% Jump Turn into More Strength? (Zacks)
Apr-30-25 05:55PM	Profound Medical: In Serious Trouble Despite Projected Growth (Seeking Alpha)
04:30PM	Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference (GlobeNewswire)
Apr-29-25 07:30AM	Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy (GlobeNewswire)
Apr-17-25 08:00AM	Profound Medical to Release First Quarter 2025 Financial Results on May 8 - Conference Call to Follow (GlobeNewswire)
Apr-15-25 07:45AM	Profound Medical AUA 2025 Investor Event Agenda (GlobeNewswire)
Mar-26-25 09:59PM	Wolf Haldenstein Adler Freeman & Herz LLP is investigating Profound Medical Corp. for potential violations of securities laws (GlobeNewswire)
08:00AM	Loading…
Mar-25-25 08:00AM	Save the Date: Profound Medical to Host Investor Event at AUA 2025 (GlobeNewswire)
Mar-07-25 02:16AM	Profound Medical Corp (PROF) Q4 2024 Earnings Call Highlights: Record Revenue and Improved ... (GuruFocus.com) -5.90%
Mar-06-25 04:05PM	Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Mar-05-25 07:23AM	What To Expect From Profound Medical Corp (TSX:PRN) Q4 2024 Earnings (GuruFocus.com)
Feb-13-25 05:00PM	Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 Conference Call to Follow (GlobeNewswire) +6.52%
Jan-13-25 08:00AM	Update: Profound Medical's Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th (GlobeNewswire)
Jan-08-25 07:30AM	Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues (GlobeNewswire)
Jan-06-25 08:15AM	Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-10-24 09:55AM	Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares (GlobeNewswire)
Dec-06-24 09:31AM	Canadian Investment Regulatory Organization Trade Resumption - PRN (PR Newswire) -6.72%
09:15AM	Canadian Investment Regulatory Organization Trading Halt - PRN (PR Newswire)
09:04AM	Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares (GlobeNewswire)
Dec-05-24 04:48PM	Profound Medical Announces Proposed Public Offering of Common Shares (GlobeNewswire)
Dec-03-24 07:46AM	Profound Medical, Siemens Healthineers enter co-sales, co-marketing agreement (TipRanks)
Dec-02-24 07:30AM	Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy (GlobeNewswire)
07:45AM	Loading…
Nov-26-24 07:45AM	Profound Medical to Unveil Next TULSA-AI Module, 'UA Alignment Assistant' (GlobeNewswire)
Nov-12-24 08:00AM	Profound Medical to Participate in the Stifel 2024 Healthcare Conference (GlobeNewswire)
Nov-08-24 12:03PM	Profound Medical Corp (PROF) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Rising Expenses (GuruFocus.com)
Nov-07-24 04:05PM	Profound Medical Announces Third Quarter 2024 Financial Results (GlobeNewswire) +12.00%
Nov-06-24 07:41AM	Profound Medical Corp (TSX:PRN) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Nov-04-24 06:55AM	Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025 (GlobeNewswire) +11.56%
Oct-17-24 04:30PM	Profound Medical to Release Third Quarter 2024 Financial Results on November 7 Conference Call to Follow (GlobeNewswire)
Oct-16-24 04:15PM	Profound Medical Appoints Tom Tamberrino as Chief Commercial Officer (GlobeNewswire)
Oct-09-24 05:58PM	Profound Medical Corp (PROF) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amidst ... (GuruFocus.com)
Sep-20-24 08:00AM	iAccess Alpha's Buyside Best Ideas Virtual Fall Conference September 24-25, 2024 (ACCESSWIRE)
Sep-16-24 08:00AM	Profound Medical's PRO-Talk Live! Event Features the Present and Future of TULSA (GlobeNewswire)
Sep-04-24 04:30PM	Profound Medical to Participate in Lake Street's Best Ideas Growth Conference (GlobeNewswire)
Aug-08-24 09:57PM	PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)
04:05PM	Profound Medical Announces Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-18-24 04:30PM	Profound Medical to Release Second Quarter 2024 Financial Results on August 8 Conference Call to Follow (GlobeNewswire)
Jul-11-24 07:00AM	Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases (GlobeNewswire)
May-16-24 09:18AM	Profound Medical (PROF) Adds AI to Prostate Cancer Treatment (Zacks)
May-15-24 05:00PM	Profound Medical Annual General Meeting of Shareholders Voting Results (GlobeNewswire)
May-14-24 07:30AM	Profound Medical Receives U.S. FDA 510(k) Clearance for 'Contouring Assistant' AI Module that Enables Creation of an Automated TULSA Treatment Plan (GlobeNewswire) +7.32%
May-13-24 10:46AM	Profound Medical Corp. (NASDAQ:PROF) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 08:55PM	PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace) +13.60% -9.27%
04:05PM	Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance (GlobeNewswire)
May-06-24 04:15PM	Growing Body of Clinical Evidence Points to the Potential of Profound Medical's TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum (GlobeNewswire)
Apr-22-24 04:15PM	Profound Medical to Release First Quarter 2024 Financial Results on May 9 Conference Call to Follow (GlobeNewswire)
Apr-09-24 07:45AM	Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference (GlobeNewswire)
Mar-08-24 03:31PM	Profound Medical Corp. (NASDAQ:PROF) Q4 2023 Earnings Call Transcript (Insider Monkey) -10.86%
Mar-07-24 09:54PM	PROF Stock Earnings: Profound Medical Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace)
04:05PM	Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-04-24 04:30PM	Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference (GlobeNewswire)
Mar-01-24 11:58AM	Profound Medical (PROF), Siemens Unite to Treat Prostate Cancer (Zacks)
Feb-27-24 07:45AM	Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure (GlobeNewswire)
Feb-15-24 04:30PM	Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 Conference Call to Follow (GlobeNewswire)
Jan-29-24 09:08AM	Profound Medical (PROF) Soars 9.4%: Is Further Upside Left in the Stock? (Zacks)
Jan-26-24 09:55AM	How Much Upside is Left in Profound Medical (PROF)? Wall Street Analysts Think 66.06% (Zacks) +9.42%
Jan-16-24 04:30PM	Profound Medical Announces Non-Brokered Private Placement (GlobeNewswire)
Jan-03-24 04:15PM	Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues (GlobeNewswire)
Dec-27-23 10:40PM	Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares (GlobeNewswire) -8.49% -5.42%
04:15PM	Profound Medical Announces Proposed Public Offering of Common Shares (GlobeNewswire)
Nov-08-23 07:45AM	Profound Medical to Participate in the Stifel 2023 Healthcare Conference (GlobeNewswire)
Nov-05-23 12:07PM	Profound Medical Corp. (NASDAQ:PROF) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-03-23 08:00AM	Profound Medical Announces CMS Extension of Temporary 'Code' for TULSA to ASC Setting (GlobeNewswire)
Nov-02-23 04:05PM	Profound Medical Announces Third Quarter 2023 Financial Results (GlobeNewswire) +8.02%
Oct-19-23 04:30PM	Profound Medical to Release Third Quarter 2023 Financial Results on November 2 Conference Call to Follow (GlobeNewswire)
Oct-10-23 04:30PM	Profound Medical 2023 Virtual Analyst & Investor Day Agenda (GlobeNewswire)
Sep-25-23 04:05PM	Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal Boost (GlobeNewswire)
Sep-21-23 08:00AM	Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13 (GlobeNewswire)
Sep-19-23 04:45PM	Profound Medical to Participate in the 2023 Cantor Global Healthcare Conference (GlobeNewswire)
Sep-06-23 07:23PM	Profound Medical Announces At-the-Market Offering of up to US$30,000,000 (GlobeNewswire) +6.50%
Aug-09-23 04:05PM	Profound Medical Announces Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-02-23 04:30PM	Profound Medical to Release Second Quarter 2023 Financial Results on August 9 Conference Call to Follow (GlobeNewswire)
Jun-02-23 01:40PM	Profound Medical Announces New CPT® Category 1 Codes from the AMA for TULSA to Treat Prostate Diseases (GlobeNewswire) +10.30%
May-30-23 08:00AM	Profound Medical Announces Upcoming Investor Events (GlobeNewswire) +5.29%
May-18-23 08:00AM	Profound Medical to Participate in A.G.P.s Virtual Healthcare Conference (GlobeNewswire)
May-17-23 04:15PM	Profound Medical Annual and Special Meeting of Shareholders Voting Results (GlobeNewswire)
May-10-23 04:05PM	Profound Medical Announces First Quarter 2023 Financial Results (GlobeNewswire)
May-01-23 04:30PM	TULSA Procedure Featured in the Scientific Program at the American Urological Association 2023 Annual Meeting (GlobeNewswire) +5.60%
Apr-19-23 04:30PM	Profound Medical to Release First Quarter 2023 Financial Results on May 10 Conference Call to Follow (GlobeNewswire) +6.07%
04:15PM	Profound Medical to to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference (GlobeNewswire)
Mar-07-23 04:05PM	Profound Medical Announces Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire) -5.56%
Mar-01-23 04:30PM	Profound Medical to Present at the 43rd Annual Cowen Health Care Conference (GlobeNewswire)
Feb-14-23 04:30PM	Profound Medical to Release Fourth Quarter and Full Year 2022 Financial Results on March 7 Conference Call to Follow (GlobeNewswire)
Nov-08-22 04:30PM	Profound Medical to Present at the 2022 Jefferies London Healthcare Conference (GlobeNewswire)
Nov-03-22 04:05PM	Profound Medical Announces Third Quarter 2022 Financial Results (GlobeNewswire) +18.62%
Oct-13-22 04:30PM	Profound Medical to Release Third Quarter 2022 Financial Results on November 3 Conference Call to Follow (GlobeNewswire)
Sep-26-22 08:00AM	Four Year Follow-Up Data from Profound Medicals TACT Pivotal Clinical Trial Confirm Durable and Stable Positive Trends Following Treatment with TULSA-PRO® of Men with Localized Prostate Cancer (GlobeNewswire)
Sep-15-22 08:00AM	Profound Medical Announces Changes to its Commercial Organization to Support Continued Growth (GlobeNewswire)
Sep-06-22 04:30PM	Profound Medical to Participate in September Investor Conferences (GlobeNewswire) -14.11%
Sep-02-22 12:05PM	Profound Medical Provides TULSA-PRO® Reimbursement Update (GlobeNewswire) -5.30%
Aug-04-22 04:05PM	Profound Medical Announces Second Quarter 2022 Financial Results (GlobeNewswire) -20.65%
Jul-14-22 04:30PM	Profound Medical to Release Second Quarter 2022 Financial Results on August 4 Conference Call to Follow (GlobeNewswire) +8.76%

Profound Medical Corp. is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the ablation of diseased tissue utilizing its platform technologies. The firm's product, the TULSA-PRO system, combines real-time MRI, robotically driven transurethral sweeping action/thermal ultrasound, and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It is also focused on developing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases. The company was founded on June 13, 2008 and is headquartered in Mississauga, Canada.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Menawat Arun Swarup	CEO	May 16 '25	Buy	4.73	12,027	56,888	587,089	May 20 01:56 PM
Menawat Arun Swarup	CEO	May 15 '25	Buy	4.33	10,003	43,263	575,062	May 20 01:56 PM
Goodman Abbey	Officer	Nov 12 '24	Proposed Sale	8.11	13,014	105,544		Nov 12 01:52 PM
Jordan-Cornet Helen	Spouse	Sep 23 '24	Proposed Sale	7.49	631	4,726		Sep 23 04:42 PM
Jordan-Cornet Helen	Spouse	Sep 18 '24	Proposed Sale	7.49	564	4,224		Sep 23 04:03 PM
Jordan-Cornet Helen	Member of immediate family of	Aug 30 '24	Proposed Sale	9.97	22	219		Aug 30 12:15 PM
Jordan-Cornet Helen	Member of immediate family of	Aug 27 '24	Proposed Sale	9.97	105	1,047		Aug 27 01:31 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PROF

Profound Medical Corp

Upgrade your FINVIZ experience